These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 8447498)
1. Chronic angiotensin-converting-enzyme inhibition improves cardiac output and fluid balance during heart failure. Brands MW; Alonso-Galicia M; Mizelle HL; Montani JP; Hildebrandt DA; Hall JE Am J Physiol; 1993 Feb; 264(2 Pt 2):R414-22. PubMed ID: 8447498 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns. Krombach RS; Clair MJ; Hendrick JW; Houck WV; Zellner JL; Kribbs SB; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG Cardiovasc Res; 1998 Jun; 38(3):631-45. PubMed ID: 9747431 [TBL] [Abstract][Full Text] [Related]
3. Circulatory and renal control by prostaglandins and renin in low cardiac output in dogs. Riegger GA; Elsner D; Kromer EP Am J Physiol; 1989 Apr; 256(4 Pt 2):H1079-86. PubMed ID: 2523199 [TBL] [Abstract][Full Text] [Related]
4. Influence of angiotensin on the early progression of heart failure. Lohmeier TE; Mizelle HL; Reinhart GA; Montani JP Am J Physiol Regul Integr Comp Physiol; 2000 Jan; 278(1):R74-86. PubMed ID: 10644624 [TBL] [Abstract][Full Text] [Related]
5. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure. Seymour AA; Asaad MM; Lanoce VM; Langenbacher KM; Fennell SA; Rogers WL J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922 [TBL] [Abstract][Full Text] [Related]
7. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure. Rademaker MT; Charles CJ; Nicholls MG; Richards AM Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934 [TBL] [Abstract][Full Text] [Related]
8. Effects of chronic angiotensin-converting enzyme inhibition on left ventricular and myocyte structure and function during recovery from chronic rapid pacing. Melton DM; Holzgrefe HH; Walker JD; Mukherjee R; Arthur SR; Antonaccio MJ; Koster WH; Spinale FG J Mol Cell Cardiol; 1997 Feb; 29(2):697-710. PubMed ID: 9140827 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin AT1 receptor inhibition, angiotensin-converting enzyme inhibition, and combination therapy with developing heart failure: cellular mechanisms of action. Spinale FG; Iannini JP; Mukherjee R; Melton DM; de Gasparo M J Card Fail; 1998 Dec; 4(4):325-32. PubMed ID: 9924854 [TBL] [Abstract][Full Text] [Related]
10. Capturing the dynamics of systemic Renin-Angiotensin-Aldosterone System (RAAS) peptides heightens the understanding of the effect of benazepril in dogs. Mochel JP; Peyrou M; Fink M; Strehlau G; Mohamed R; Giraudel JM; Ploeger B; Danhof M J Vet Pharmacol Ther; 2013 Apr; 36(2):174-80. PubMed ID: 22568394 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibition and angiotensin II subtype-1 receptor blockade during the progression of left ventricular dysfunction: differential effects on myocyte contractile processes. Spinale FG; Holzgrefe HH; Mukherjee R; Webb ML; Hird RB; Cavallo MJ; Powell JR; Koster WH J Pharmacol Exp Ther; 1997 Dec; 283(3):1082-94. PubMed ID: 9399980 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin II receptor blocker add-on therapy for low cardiac output in decompensated heart failure. Ochiai ME; Barretto AC; Cardoso JN; Munhoz RT; Morgado PC; Ramires JA Arq Bras Cardiol; 2010 Feb; 94(2):219-22, 235-8, 222-5. PubMed ID: 20428619 [TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of angiotensin and renin inhibition in dogs with acute left ventricular failure. Sweet CS; Ludden CT; Frederick CM; Ribeiro LG Am J Med; 1984 Aug; 77(2A):7-12. PubMed ID: 6089558 [TBL] [Abstract][Full Text] [Related]
14. Effects of renin inhibition compared to angiotensin converting enzyme inhibition in conscious dogs with pacing-induced heart failure. Shannon RP; Friedrich S; Mathier M; Knight DR Cardiovasc Res; 1997 Jun; 34(3):464-72. PubMed ID: 9231029 [TBL] [Abstract][Full Text] [Related]
15. The acute renal actions of angiotensin converting enzyme inhibitors in the sodium-depleted conscious primate are mediated by inhibition of the renin-angiotensin system. Humke U; Levens N; Wood J; Hofbauer K J Pharmacol Exp Ther; 1992 Jan; 260(1):29-35. PubMed ID: 1309874 [TBL] [Abstract][Full Text] [Related]
16. Addition of angiotensin II receptor antagonist to an ACE inhibitor in heart failure improves cardiovascular function by a bradykinin-mediated mechanism. Koji T; Onishi K; Dohi K; Okamoto R; Tanabe M; Kitamura T; Ito M; Isaka N; Nobori T; Nakano T J Cardiovasc Pharmacol; 2003 Apr; 41(4):632-9. PubMed ID: 12658066 [TBL] [Abstract][Full Text] [Related]
17. Effect of tepoxalin on renal function in healthy dogs receiving an angiotensin-converting enzyme inhibitor. Fusellier M; Desfontis JC; Madec S; Gautier F; Marescaux L; Debailleul M; Gogny M J Vet Pharmacol Ther; 2005 Dec; 28(6):581-6. PubMed ID: 16343292 [TBL] [Abstract][Full Text] [Related]
18. Effects of inhibition of the maternal renin-angiotensin system on maternal and fetal responses to drainage of fetal fluids. Lumbers ER; Bernasconi C; Burrell JH Can J Physiol Pharmacol; 1996 Aug; 74(8):973-82. PubMed ID: 8960388 [TBL] [Abstract][Full Text] [Related]
19. Role of renal nerves in control of sodium excretion in chronic congestive heart failure. Mizelle HL; Hall JE; Montani JP Am J Physiol; 1989 Jun; 256(6 Pt 2):F1084-93. PubMed ID: 2525344 [TBL] [Abstract][Full Text] [Related]
20. Blood pressure early in diabetes depends on a balance between glomerular filtration rate and the renin-angiotensin system. Rojas M; Bell TD; Sturgis LC; Springfield V; Janardhanan R; Fleming C; Brands MW Am J Hypertens; 2006 Dec; 19(12):1249-55. PubMed ID: 17161770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]